Research and Markets: Clinical Data Inc. Scrutinised in New Product Pipeline Report
Posted on: Friday, 30 November 2007, 06:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c75974) has announced the addition of Clinical Data Inc. - Product Pipeline Report to their offering.
The Clinical Data Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.
Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.
Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The Clinical Data Inc Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on Clinical Data Incs current pipeline portfolio.
Product Pipeline Reports Business Summary Contact Information Selected Financial Data Company Details Product Glance (Table/Graph) Disease Hub Classification (Table/Graph) Product Pipeline Product Catalog Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc. Patent Details (if any) Recent Financings Trademarks Deals & Alliances Management Profile Recent Updates
For more information visit http://www.researchandmarkets.com/reports/c75974
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Data From Clinical Trial of EndoBarrier(TM) Gastrointestinal Liner in Patients With Type 2 Diabetes to Be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York City
- Sunesis Pharmaceuticals Presents Data From Clinical Trials of Voreloxin (Formerly SNS-595) in Patients With Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
- Health Enhancement Products Announces Final Results of Clinical Trials of ProAlgaZyme in Metabolic Syndrome and HIV Patients
- OREXIGEN(TM) Therapeutics Expands Senior Management Team As Lead Products Advance Through Late-Stage Clinical Trials
- CepTor Signs Letter of Intent With Ferring Pharmaceuticals for Superoxide Dismutase; Product Targeted for Phase 2B Clinical Trials for Prevention of Chronic Respiratory Morbidity in Premature Newborns
- Details of Human Clinical Trial and HDL Selective Delipidation Business Model Discussed During Presentation at Lipid Sciences' Annual Meeting of Stockholders
- The American Journal of Psychiatry Publishes Data on Clinical Trial of Nalmefene in the Treatment of Pathological Gambling
- State May Require Details of Drug Clinical Trials
- Callisto Pharmaceuticals Announces Details of Upcoming Clinical Trial of Annamycin in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia Patients
- Aphton Corporation Reports Data From Clinical Trial of Insegia in Combination With Chemotherapy in Pancreatic Cancer
 |
 |
User Comments (0)
RSS Feeds